Apnimed, Inc. APMD
14.79 USD -0.27 (-1.78%)
Nov 4, 2026, 11:00 AM EST
14.81 Day range 15.61
14.81 52-week range 35.29
- YTD
- -40.83%
- 1 year
- -40.83%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 50.33 +240.3% upside
Now 14.79
- Target (low)
- 41.00
- Target (mean)
- 50.33
- Target (high)
- 60.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.34 | -0.54 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next quarter | -0.60 | -0.80 – -0.59 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Current year | -0.06 | -0.06 – -0.06 | 0.00 | 0.0% | 90.85M | 0.0% | 1 |
| Next year | -3.98 | -5.55 – -1.39 | -0.06 | -6525.0% | 22.44M | -75.3% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 25, 2026 | LifeSci Capital | Initiated | — | Outperform |
| Aug 25, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Aug 25, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| Aug 25, 2026 | B of A Securities | Initiated | — | Buy |